Visium Asset Management’s Assembly Biosciences ASMB Stock Holding History

Visium Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-142,499	Closed	-$8.58M	–	354
2016 Q1	$8.58M	Buy	142,499 +832	+0.6%	+$55.6K	0.15%	173
2015 Q4	$12.8M	Buy	141,667 +8,334	+6%	+$908K	0.19%	122
2015 Q3	$15.3M	Buy	133,333 +8,333	+7%	+$1.47M	0.21%	100
2015 Q2	$28.9M	Hold	125,000	–	–	0.41%	43
2015 Q1	$19.9M	Buy	125,000 +55,476	+80%	+$7.51M	0.29%	73
2014 Q4	$6.56M	Buy	69,524 +32,024	+85%	+$3.16M	0.09%	195
2014 Q3	$3.69M	Buy	37,500 +7,500	+25%	+$665K	0.05%	339
2014 Q2	$2.36M	Hold	30,000	–	–	0.04%	374
2014 Q1	$2.3M	Hold	30,000	–	–	0.04%	363
2013 Q4	$6.88M	Buy	30,000 +5,000	+20%	+$910K	0.14%	144
2013 Q3	$4.33M	Hold	25,000	–	–	0.1%	167
2013 Q2	$3.6M	Buy	+25,000	New	+$3.92M	0.08%	154

Other funds holding ASMB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Visium Asset Management's ASMB Position: Q2 2016 in Review

Visium Asset Management sold out of Assembly Biosciences (ASMB) in Q2 2016, closing a stake of 142,499 shares — an estimated $8.58M sold.

Visium Asset Management first reported a position in ASMB in Q2 2013 and held it in 12 quarters. The position peaked at $28.9M in Q2 2015. 43 funds tracked by Wall St. Rank hold ASMB as of Q2 2016.

Visium Asset Management reported no remaining Assembly Biosciences position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 142,499 Assembly Biosciences shares in Q2 2016, an estimated $8.58M.
Visium Asset Management first reported a position in Assembly Biosciences in Q2 2013 and held it in 12 quarters.
Visium Asset Management's Assembly Biosciences position peaked at $28.9M in Q2 2015.
43 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.